Brevan Howard Capital Management LP

Position in A — Agilent Technologies, Inc.

CIK 1512857 ST. HELIER, Y9

Position in A

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,066,692

+$2,821,516 QoQ

Shares Held

35,679

+289.9% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brevan Howard Capital Management LP holds $32,347,391 across 20 Diagnostics & Research names. A ranks #4 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	30,881	$6,175,891
2	QGEN	Qiagen N.V.	133,177	$5,332,407
3	DHR	Danaher Corp /De/	21,586	$4,092,705
4	A	Agilent Technologies, Inc. This page	35,679	$4,066,692
5	ADPT	Adaptive Biotechnologies Corp	170,928	$2,372,480
6	RVTY	Revvity, Inc.	26,071	$2,284,080
7	SHC	Sotera Health Co	127,142	$1,823,216
8	IQV	Iqvia Holdings Inc.	7,723	$1,317,080

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,066,692	35,679	+289.9%	Shares	Defined	2026-05-15
2025-12-31	$1,245,176	9,151	+147.8%	Shares	Defined	2026-02-17
2025-09-30	$473,996	3,693	-9.6%	Shares	Defined	2025-11-14
2025-06-30	$481,952	4,084	-38.6%	Shares	Defined	2025-08-14
2023-12-31	$924,687	6,651	+6.0%	Shares	Defined	2024-02-14
2023-09-30	$701,446	6,273	0.0%	Shares	Defined	2023-11-14
2023-06-30	$754,328	6,273	0.0%	Shares	Defined	2023-08-14
2023-03-31	$867,806	6,273	0.0%	Shares	Defined	2023-05-15
2022-12-31	$938,754	6,273	0.0%	Shares	Defined	2023-02-14
2022-09-30	$762,483	6,273	+188.7%	Shares	Defined	2022-11-14
2022-06-30	$258,087	2,173	0.0%	Shares	Defined	2022-08-15
2022-03-31	$287,553	2,173	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.